Sign in
4/A

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0001062993-25-001501

Options or other derivatives

  • President - DGS acquired 15,825 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
McManus Matthew President - DGS 2024-08-15 Grant or award · Performance Restricted Stock Units +15,825 15,825 D
Loading xslF345X05/form4a.xml…